Pular para o conteúdo principal

ETHNOS_APP

Início • Busca • Periódicos • Lista 0

Ingrid Agartz

Dados Biográficos

ID1982160
NOMEIngrid Agartz
PRENOMESIngrid
SOBRENOMEAgartz
ASSINATURAAGARTZ I
AFILIAÇÕESUniversity of Oslo
ORCID0000-0002-9839-5391
VERIFICADOSim
TOTAL DE OBRAS8
TOTAL DE CITAÇÕES0
TOTAL COMO AUTOR8
TOTAL COMO EDITOR0
PRIMEIRO ANO DE PUBLICAÇÃO2014
ANO MAIS RECENTE DE PUBLICAÇÃO2023
ÍNDICE H0
  • Adolescent Psychosis

    Ingrid Agartz, Runar Smelror•BOOK•Adolescent Psychosis•2023

  • Mapping genomic loci implicates genes and synaptic biology in schizophrenia

    Open Access•Vassily Trubetskoy, Antonio F Pardiñas et al.•ARTICLE•Nature•2022

  • Negative Symptom Domains Are Associated With Verbal Learning in Adolescents With Early Onset Psychosis

    Open Access•Lynn Mørch‐Johnsen, Lynn Mørch-Johnsen et al.•ARTICLE•Frontiers in Psychiatry•2022

    Background: Early-onset psychosis (EOP) is among the leading causes of disease burden in adolescents. Negative symptoms and cognitive deficits predicts poorer functional outcome. A better understanding of the association between negative symptoms and cognitive impairment may inform theories on underlying mechanisms and elucidate targets for development of new treatments. Two domains of negative symptoms have been described in adult patients with …

  • Autoantibodies to the N-Methyl-D-Aspartate Receptor in Adolescents With Early Onset Psychosis and Healthy Controls

    Open Access•Kristine Engen, Laura A Wortinger et al.•ARTICLE•Frontiers in Psychiatry•2020

    We report that a small number of EOP patients and HC have NMDAR-Abs with a similar frequency in both groups. The presence of the antibodies was not associated with any distinctive clinical or radiological features. Detection of the antibodies had no diagnostic implication, and a positive NMDAR antibody test must be carefully interpreted and reviewed within the individual clinical context

  • Microstructural White Matter and Links With Subcortical Structures in Chronic Schizophrenia

    Open Access•Tiril P Gurholt, Unn K Haukvik et al.•ARTICLE•Frontiers in Psychiatry•2020

    Schizophrenia is a severe mental disorder with often a chronic course. Neuroimaging studies report brain abnormalities in both white and gray matter structures. However, the relationship between microstructural white matter differences and volumetric subcortical structures is not known. We investigated 30 long-term treated patients with schizophrenia and schizoaffective disorder (mean age 51.1 ± 7.9 years, mean illness duration 27.6 ± 8.0 years) …

  • Identification of neurobehavioural symptom groups based on shared brain mechanisms

    Open Access•Alex Ing, Philipp G Sämann et al.•ARTICLE•Nature Human Behaviour•2019•Referências: 76

  • Biclustered Independent Component Analysis for Complex Biomarker and Subtype Identification from Structural Magnetic Resonance Images in Schizophrenia

    Open Access•Cota Navin Gupta, Eduardo Castro et al.•ARTICLE•Frontiers in Psychiatry•2017

    Clinical and cognitive symptoms domain-based subtyping in schizophrenia (Sz) has been critiqued due to the lack of neurobiological correlates and heterogeneity in symptom scores. We, therefore, present a novel data-driven framework using biclustered independent component analysis to detect subtypes from the reliable and stable gray matter concentration (GMC) of patients with Sz. The developed methodology consists of the following steps: source-ba…

  • Neurocognitive Decrements are Present in Intellectually Superior Schizophrenia

    Open Access•Anja Vaskinn, Torill Ueland et al.•ARTICLE•Frontiers in Psychiatry•2014

    Data suggest that individuals with schizophrenia (SZ) and superior intelligence can present without specific neurocognitive deficits. However, neurocognitive decrements, defined as worse cognition than expected, have been reported in practically all SZ cases. This study investigated if neurocognitive decrements are present in intellectually superior SZ by comparing the neuropsychological profile of SZ cases with IQ-matched healthy controls (HC) a…

Sem obras proeminentes nesta página.

  • Neurocognitive Decrements are Present in Intellectually Superior Schizophrenia

    Open Access•Anja Vaskinn, Torill Ueland et al.•ARTICLE•Frontiers in Psychiatry•2014

    Data suggest that individuals with schizophrenia (SZ) and superior intelligence can present without specific neurocognitive deficits. However, neurocognitive decrements, defined as worse cognition than expected, have been reported in practically all SZ cases. This study investigated if neurocognitive decrements are present in intellectually superior SZ by comparing the neuropsychological profile of SZ cases with IQ-matched healthy controls (HC) a…

  • Biclustered Independent Component Analysis for Complex Biomarker and Subtype Identification from Structural Magnetic Resonance Images in Schizophrenia

    Open Access•Cota Navin Gupta, Eduardo Castro et al.•ARTICLE•Frontiers in Psychiatry•2017

    Clinical and cognitive symptoms domain-based subtyping in schizophrenia (Sz) has been critiqued due to the lack of neurobiological correlates and heterogeneity in symptom scores. We, therefore, present a novel data-driven framework using biclustered independent component analysis to detect subtypes from the reliable and stable gray matter concentration (GMC) of patients with Sz. The developed methodology consists of the following steps: source-ba…

  • Identification of neurobehavioural symptom groups based on shared brain mechanisms

    Open Access•Alex Ing, Philipp G Sämann et al.•ARTICLE•Nature Human Behaviour•2019•Referências: 76

  • Autoantibodies to the N-Methyl-D-Aspartate Receptor in Adolescents With Early Onset Psychosis and Healthy Controls

    Open Access•Kristine Engen, Laura A Wortinger et al.•ARTICLE•Frontiers in Psychiatry•2020

    We report that a small number of EOP patients and HC have NMDAR-Abs with a similar frequency in both groups. The presence of the antibodies was not associated with any distinctive clinical or radiological features. Detection of the antibodies had no diagnostic implication, and a positive NMDAR antibody test must be carefully interpreted and reviewed within the individual clinical context

  • Microstructural White Matter and Links With Subcortical Structures in Chronic Schizophrenia

    Open Access•Tiril P Gurholt, Unn K Haukvik et al.•ARTICLE•Frontiers in Psychiatry•2020

    Schizophrenia is a severe mental disorder with often a chronic course. Neuroimaging studies report brain abnormalities in both white and gray matter structures. However, the relationship between microstructural white matter differences and volumetric subcortical structures is not known. We investigated 30 long-term treated patients with schizophrenia and schizoaffective disorder (mean age 51.1 ± 7.9 years, mean illness duration 27.6 ± 8.0 years) …

  • Mapping genomic loci implicates genes and synaptic biology in schizophrenia

    Open Access•Vassily Trubetskoy, Antonio F Pardiñas et al.•ARTICLE•Nature•2022

  • Negative Symptom Domains Are Associated With Verbal Learning in Adolescents With Early Onset Psychosis

    Open Access•Lynn Mørch‐Johnsen, Lynn Mørch-Johnsen et al.•ARTICLE•Frontiers in Psychiatry•2022

    Background: Early-onset psychosis (EOP) is among the leading causes of disease burden in adolescents. Negative symptoms and cognitive deficits predicts poorer functional outcome. A better understanding of the association between negative symptoms and cognitive impairment may inform theories on underlying mechanisms and elucidate targets for development of new treatments. Two domains of negative symptoms have been described in adult patients with …

  • Adolescent Psychosis

    Ingrid Agartz, Runar Smelror•BOOK•Adolescent Psychosis•2023

Psychiatry (6 obras) · Psychology (6 obras) · Medicine (5 obras) · Schizophrenia (object-oriented programming (4 obras) · Clinical Psychology (3 obras) · Functional Brain Connectivity Studies (3 obras) · Internal Medicine (3 obras) · Magnetic resonance imaging (3 obras) · Radiology (3 obras) · Biology (2 obras)

Ethnos_APP • Projeto Open Source • Licença MIT • Frontend v2.0.0 • Privacidade e Cookies • Documentação da API: api.ethnos.app/docs • Código da API: GitHub • DOI: 10.5281/zenodo.17049435 • Código do Frontend: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae